Array BioPharma (ARRY)

Add to Watchlists
Create an Alert
3.79 -0.05  -1.30% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD

Array BioPharma Net Income (Quarterly):

-16.41M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Array BioPharma Net Income (Quarterly) Chart

Export Data
Save Image

Array BioPharma Historical Net Income (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -16.41M
Sept. 30, 2013 -15.68M
June 30, 2013 -17.65M
March 31, 2013 -21.59M
Dec. 31, 2012 -10.93M
Sept. 30, 2012 -11.77M
June 30, 2012 -8.027M
March 31, 2012 -8.168M
Dec. 31, 2011 -3.803M
Sept. 30, 2011 -3.58M
June 30, 2011 -21.75M
March 31, 2011 -11.50M
Dec. 31, 2010 -12.44M
Sept. 30, 2010 -10.63M
June 30, 2010 -15.85M
March 31, 2010 -15.16M
Dec. 31, 2009 -21.82M
Sept. 30, 2009 -24.80M
June 30, 2009 -26.70M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Get data for
Advertisement

ARRY Net Income (Quarterly) Benchmarks

Companies
Celldex Therapeutics -22.06M
Oncothyreon -16.40M
Cytokinetics 6.531M

ARRY Net Income (Quarterly) Range, Past 5 Years

Minimum -26.70M Jun 2009
Maximum -3.580M Sep 2011
Average -14.65M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.